USE OF BOX–BEHNKEN DESIGN FOR OPTIMIZATION OF COMPOUNDED MEDICATION: ACYCLOVIR CAPSULES REPORT

USE OF BOX–BEHNKEN DESIGN FOR OPTIMIZATION OF COMPOUNDED MEDICATION: ACYCLOVIR CAPSULES REPORT

Show other versions (4)

Campus compounding pharmacies play an important role in public health. Herpes simplex is one of the most common viral diseases in humans, which generates a great demand for acyclovir capsules in compounding pharmacy. It is well known that the formulation's components influence the effectiveness...

Full description

Bibliographic Details
Main Authors:	Suelen da Silva Reis, Valdemir da Silva Quintanilha Junior, Gabriella da Silva Boto, Thalita Martins da Silva, Elizabeth Valverde Macedo, Carlos Augusto de Freitas Peregrino, Samanta Cardozo Mourão, Emeli Moura de Araújo
Format:	Article
Language:	English
Published:	Universidade Federal do Rio Grande do Sul 2021-06-01
Series:	Drug Analytical Research
Subjects:	acyclovir dissolution excipients design of experiment capsules
Online Access:	https://seer.ufrgs.br/dar/article/view/113283/63279

Similar Items

Use of Box–Behnken design for optimization of compounded medication: acyclovir capsules report
by: Suelen da Silva Reis, et al.
Published: (2021-06-01)

Use of Box–Behnken design for optimization of compounded medication: acyclovir capsules report
by: Suelen da Silva Reis, et al.
Published: (2021-06-01)

Use of Box–Behnken design for optimization of compounded medication: acyclovir capsules report
by: Suelen da Silva Reis, et al.
Published: (2021-06-01)

Use of Box–Behnken design for optimization of compounded medication: acyclovir capsules report
by: Suelen da Silva Reis, et al.
Published: (2021-06-01)

Improvement of physicochemical parameters of acyclovir using cocrystallization approach
by: Jignasa Ketan Savjani, et al.

Enhanced gastric residence time of acyclovir by floating raft formulation using box-behnken design
by: Rajalakshmi Munusamy, et al.
Published: (2024-01-01)

Incidence, patterns, risk factors and clinical outcomes of intravenous acyclovir induced nephrotoxicity
by: Abdullah M. Al-Alawi, et al.
Published: (2022-06-01)

Pharmaceutical evaluation of compounded furosemide capsules and excipient performance
by: Pabllo Adelino Estevam Barbosa, et al.
Published: (2022-11-01)

Physicochemical characterization and dissolution studies of acyclovir solid dispersions with Pluronic F127 prepared by the kneading method
by: Karolewicz Bożena, et al.
Published: (2016-03-01)

Formulation and Evaluation of Acyclovir Microspheres
by: Pavani s, et al.
Published: (2018-06-01)

Is acyclovir effective for the treatment of varicella in children and adolescents?
by: Felipe González
Published: (2018-10-01)

In vitro evaluation of cutaneous penetration of acyclovir from semisolid commercial formulations and relation with its effective antiviral concentration
by: Rafaela Martins Sponchiado, et al.

Vitreous pharmacokinetics and electroretinographic findings after intravitreal injection of acyclovir in rabbits
by: Francisco Max Damico, et al.
Published: (2012-08-01)

The efficacy of acyclovir in treatment of the pemphigus vulgaris
by: Fariba Iraji, et al.
Published: (2013-01-01)

Oral acyclovir induced hypokalemia and acute tubular necrosis a case report
by: Jonathan S. Chávez-Iñiguez, et al.
Published: (2018-11-01)

The Role of Functional Excipients in Solid Oral Dosage Forms to Overcome Poor Drug Dissolution and Bioavailability
by: Jannes van der Merwe, et al.
Published: (2020-04-01)

Development of solid lipid nanoparticles for oral delivery of acyclovir and evaluation of its pharmacokinetics profile
by: Hassan, Haniza
Published: (2018)

Bullous cutaneous eruption due to extravasation of acyclovir in a child with acute lymphoblastic leukemia
by: Abdurrahman Sarıca
Published: (2012-03-01)

Acyclovir in bipolar disorder: A mismatched combination?
by: Naveen Jayaram, et al.
Published: (2011-01-01)

Sustained release of acyclovir from alginate-gellan gum and alginate-xanthan gum microbeads
by: Sudipta Das, et al.
Published: (2024-04-01)

Formulation and evaluation of Acyclovir compressed lozenges
by: Dalya Badry Khudhair, et al.
Published: (2022-04-01)

Anti-CyHV-3 effect of fluorescent, tricyclic derivative of acyclovir 6-(4-MeOPh)-TACV in vitro
by: Troszok Agnieszka, et al.
Published: (2019-10-01)

The effects of oral Acyclovir in the treatment of necrotizing Herpetic keratouveitis
by: "Hosseini Tehrani M;Poormostadam B;Vallaei N;Raiszadeh F "
Published: (2000-03-01)

The effects of oral Acyclovir in the treatment of necrotizing Herpetic keratouveitis
by: "Hosseini Tehrani M;Poormostadam B;Vallaei N;Raiszadeh F "
Published: (2000-08-01)

Derivative spectrophotometric method for determination of acyclovir in polymeric nanoparticles
by: Guilherme Diniz Tavares, et al.
Published: (2012-01-01)

Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase
by: Carlos von Plessing Rossel, et al.
Published: (2000-12-01)

Critical Review of Synthesis, Toxicology and Detection of Acyclovir
by: Yan-Ping Wei, et al.
Published: (2021-10-01)

Preparation of Acyclovir-Containing Solid Foam by Ultrasonic Batch Technology
by: Ádám Haimhoffer, et al.
Published: (2021-09-01)

Acyclovir in pityriasis rosea: An observer-blind, randomized controlled trial of effectiveness, safety and tolerability
by: Anupam Das, et al.
Published: (2015-01-01)

The comparison between the efficacy of high dose acyclovir and erythromycin on the period and signs of pitiriasis rosea
by: Ehsani Amirhooshang, et al.
Published: (2010-01-01)

Clinical efficacy of oral and topical acyclovir in herpes simplex virus stromal necrotizing keratitis
by: Surabhi Dutt, et al.
Published: (2016-01-01)

Intraosseous infusion of acyclovir in a neonate
by: Saverio De Marca, et al.
Published: (2022-09-01)

The Efficacy of Acyclovir in Childhood Bell’s Palsy
by: Gürkan Gürbüz
Published: (2020-06-01)

SEARCH OF INHIBITORS OF HERPES VIRAL REPLICATION: 30 YEARS AFTER ACYCLOVIR
by: Korovina A. N., et al.
Published: (2013-08-01)

Formulation and evaluation of mucoadhesive buccal patch of acyclovir utilizing inclusion phenomenon
by: Ankita Saxena, et al.
Published: (2011-12-01)

Bullous eruptions in a preschool child: A rare adverse effect of acyclovir
by: Nidhi Garg, et al.
Published: (2020-01-01)

Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients
by: Natalia Maximova, et al.
Published: (2022-04-01)

Preliminary Study for the Preparation of Transmucosal or Transdermal Patches with Acyclovir and Lidocaine
by: Cristina-Adela Marioane, et al.
Published: (2021-10-01)

The use of high-dose acyclovir in patients with hematological malignancies who develop herpes virus infections: Is it really safe?
by: Ismail Sarı, et al.
Published: (2008-12-01)

The Effects and Pharmacokinetics of Acyclovir in Neonates
by: Gian Maria Pacifici
Published: (2016-12-01)